Currently, PKM2 is known as the cancer-specific PK isozyme, as its dimeric form has been associated with oncogenesis, acting as cancer-specific signaling molecules such as STAT3, histone H3, OCT-4 and HIF-1 [50,51]. This evidence concerns the gene PKM and cancer.